- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 311/32 - Dérivés dihydro-2, 3, p. ex. flavanones
Détention brevets de la classe C07D 311/32
Brevets de cette classe: 145
Historique des publications depuis 10 ans
|
9
|
5
|
8
|
11
|
18
|
8
|
13
|
11
|
10
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Mcmaster University | 834 |
5 |
| HealthTech Bio Actives, S.L.U. | 25 |
5 |
| Shanghai Spark Pharmaceutical Co, Ltd | 14 |
5 |
| Suntory Holdings Limited | 2207 |
4 |
| Hefei Lifeon Pharmaceutical Co. Ltd. | 11 |
4 |
| Flavocure Biotech, Inc. | 10 |
4 |
| Northwestern University | 3570 |
3 |
| Citrox Biosciences Limited | 26 |
3 |
| Firmenich SA | 1776 |
3 |
| Fuso Pharmaceutical Industries, Ltd. | 115 |
3 |
| Kinki University | 253 |
3 |
| Ingredients by Nature | 3 |
3 |
| Hoffmann-La Roche Inc. | 3841 |
2 |
| Agency for Science, Technology and Research | 3765 |
2 |
| The Hong Kong Polytechnic University | 550 |
2 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 188 |
2 |
| National University Corporation University of Toyama | 185 |
2 |
| Piramal Enterprises Limited | 151 |
2 |
| Pokka Corporation | 8 |
2 |
| Rutgers, The State University of New Jersey | 1988 |
2 |
| Autres propriétaires | 84 |